NBI-69733

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNBI-69733
Drug Alias NameNBI-69733PNU-142774
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSexual Dysfunctions, PsychologicalErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncNeurocrine Biosciences Inc
Active IndicationsN/A
Inactive IndicationsSexual Dysfunctions, PsychologicalErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A